combined use of novel biomarkers for heart failure risk stratification vs conventional assessment
Published 11 years ago • 310 plays • Length 6:30Download video MP4
Download video MP3
Similar videos
-
0:46
novel and emerging biomarkers for cardiovascular risk stratification: role of inflammatory and other
-
28:03
marc penn md, phd facc, novel biomarkers for risk stratifying patients for cardiovascular risk
-
31:33
novel biomarkers for risk stratification
-
50:26
biomarkers in heart failure: how to guide clinicians
-
56:11
biomarker guided therapy for heart failure: the guide-it study
-
17:40
novel biomarkers of cardiovascular risk: an unbiased proteomic approach | peter ganz
-
15:54
cardiovascular biomarkers of atherosclerotic risk
-
2:22
heart failure (hfpef) | endotrophin as a novel biomarker | pro-c6
-
2:38
biomarkers and heart failure
-
11:55
aacc 2014 in booth presentation: risk stratification in heart failure
-
19:57
cardiovascular laboratory: biomarkers, testing, & clinical implications
-
15:09
dr. a k pancholia - clinical features, biomarkers & risk stratification in heart failure
-
4:30
cardiology countdown | biomarkers and novel anticoagulants by chads2 risk score
-
0:56
biomarkers for risk assessment and early diagnosis of ad
-
49:33
unmet clinical needs assessment for biomarker evaluation
-
5:51
using biomarkers in treatment of heart failure
-
3:02
advancing diagnostic biomarkers for cardiovascular disease
-
59:27
alan maisel - pro enkephalin a novel new biomarker for assessment of kidney function, early predict